key: cord-1030672-uqq1rina
authors: Rasmussen, M. I.; Hansen, M. L.; Pichler, G.; Dempsey, E.; Pellicer, A.; EL-Khuffash, A.; A, S.; Piris-Borregas, S.; Alsina, M.; Cetinkaya, M.; Chalak, L.; Ozkan, H.; Baserga, M.; Sirc, J.; Fuchs, H.; Ergenekon, E.; Arruza, L.; Mathur, A.; Stocker, M.; Otero-Vaccarello, O.; Szczapa, T.; Sarafidis, K.; Krolak-Olejnik, B.; Memisoglu, A.; Reigstad, H.; Rafinska-Wazny, E.; Hatzidaki, E.; Peng, Z.; Gkentzi, D.; Viellevoye, R.; De Buyst, J.; Mastretta, E.; Wang, P.; Hahn, G.; Bender, L.; Cornette, L.; Tkaczyk, J.; del Rio, R.; Fumagalli, M.; Papathoma, E.; Wilinska, M.; Naulers, G.; Sadowska-Kakrawc,
title: Extremely preterm infant admissions within the SafeBoosC-III consortium during the COVID-19 lockdown
date: 2020-10-05
journal: nan
DOI: 10.1101/2020.10.02.20204578
sha: 019e1ffd1034a1b9ff9c0545d39eaa8548f705aa
doc_id: 1030672
cord_uid: uqq1rina

Objective: To evaluate if the number of admitted extremely preterm (EP) infants (born before 28weeks of gestational age) has changed in the neonatal intensive care units (NICUs) of the SafeBoosC-III consortium during the global lockdown when compared to the corresponding time period in 2019. Design: This is a retrospective, observational study. Forty-six out of 79 NICUs (58%) from 17 countries participated. Principal investigators were asked to report the following information: 1) Total number of EP infant admissions to their NICU in the three months where the lockdown restrictions were most rigorous during the first phase of the COVID-19 pandemic, 2) Similar EP infant admissions in the corresponding three months of 2019, 3) the level of local restrictions during the lockdown period and 4) the local impact of the COVID-19 lockdown on the everyday life of a pregnant woman. Results: There was no significant difference between the number of EP infant admissions during the three most rigorous lockdown months of the COVID-19 pandemic compared to the corresponding three months in 2019 (n=428 versus n=457 respectively, p=0.33). There were no significant changes within individual geographic regions and no significant association between the level of lockdown restrictions and change in the number of EP infant admissions (p=0.334). Conclusion: This larger ad hoc study did not confirm previous studies report of a major reduction in the number of extremely preterm births during the first phase of the COVID-19 pandemic.

On the 11 th of March 2020, COVID-19 was declared a pandemic by the World Health Organisation, which led to an almost worldwide lockdown (1) . During the lockdown, reductions in extremely preterm birth rates and extremely low birth weight infants have been reported in Danish (2) and

Irish (3) studies. The Danish study reported a decrease in the number of infants born extremely preterm (EP, infant born before 28 weeks gestational age). The study reported one EP infant from the 12 th of March to the 14 th of April of 2020 compared to a mean of 11.4 over the same time period of the preceding five years, in all of Denmark (2) . The same trend was seen in the Irish study, relying on data from one hospital in Ireland, where no extremely low birth weight infants (<1000gm) were born from January to April in 2020, compared to a mean of 4.9 from January to April during the preceding 20 years (3) . A Nepalese study (4) based on nine health institutions reported the contrary, with an increase in the preterm birth rate (infants born before 37 weeks gestational age) from 16.7% (2125 preterm births out of 13189 births) between 1 st of January to 30 th of May 2019 to 20.0% between 1 st of January to 30 th of May 2020 (1342 preterm births out of 7165 births). However, as can be seen in the numbers, the overall registered number of births in the time period dropped from 13189 in 2019 to 7165 in 2020. Thus, it is plausible that healthy mothers with uncomplicated pregnancies delivering at term age might have given birth outside the hospitals, while babies delivered preterm may have happened at the hospitals as usual (4) .

Regarding the Danish and Irish studies, the number of extremely preterm and extremely low birth weight infants were small and thus, the results should be interpreted with caution (5) . An article in the New York Times additionally reported that several neonatologists from neonatal intensive care units (NICU) worldwide, had observed a decrease in local prematurity rates, while other neonatologists observed the contrary (6) . The same observations were reported within the SafeBoosC-III consortium through verbal communication.

The COVID-19 pandemic has disrupted clinical trials across the world and affected the ability to conduct trials in a safe and effective manner (7) . Thus, many trials have slowed down, been suspended, or even terminated, due to the difficulties of conducting research under lockdown conditions (7) . The SafeBoosC-III trial investigates the benefit and harms of treatment guided by cerebral near-infrared spectroscopy monitoring compared with treatment and monitoring as usual in extremely preterm infants (8) . Despite having a vulnerable population, potentially at increased risk of complications to a COVID-19 infection, the trial was able to proceed in most countries. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Randomisations per NICU per month All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted October 5, 2020. . https://doi.org/10.1101/2020.10.02.20204578 doi: medRxiv preprint

This is a retrospective, observational study, based on the NICUs in the consortium of the SafeBoosC-III randomised clinical trial (8) . The principal investigators from all of the 79 NICUs in the consortium, were invited to participate in this study by e-mail and asked to report the following information: 1) the number of EP infants admitted to their NICU within the three months, where the lockdown restrictions were most rigorous during the first phase of the COVID-19 pandemic, 2) the number of EP infants admitted within the corresponding three months of 2019, and 3) the level of restrictions imposed upon the public, during the most rigorous three months of the lockdown period, in a Likert scale format from one to five. The consecutive three months where the lockdown restrictions were most rigorous during the first phase of the COVID-19 pandemic were subjectively defined by local principal investigators. The scale used to classify the level of lockdown restriction, is a modified scale inspired from the New Zealand COVID-19 alert system (9) , with one being the normal state of society, two being mild restrictions, three being moderate restrictions, four being strong restrictions and five being very strong restrictions (full scale in appendix 1). Principal investigators reported that the data on the number of EP infant admissions was collected from admissions logbooks, NICU databases, hospital databases, and in one case, from a national registry.

Investigators were also asked to categorise the impact of the COVID-19 lockdown on the everyday life of a pregnant woman, and additionally, if they believed that the lockdown restrictions could possibly lead to a non-admittance of EP infants (e.g. intrauterine death due to delayed admittance of the mother, no possibility to transfer the baby from place of birth to a tertiary centre). Lastly, investigators were asked if there within the last year had been any major changes in the organisation of perinatal care in their area/region, which may have changed the number of EP infant admissions to their respective NICU. The full data report template can be found in appendix 1.

The primary outcome was the difference in the total number of EP infant admissions during the three months with the most rigorous lockdown restrictions during the first phase of the COVID-19

pandemic, compared to the corresponding three months in 2019.

Secondary outcomes were 1) The change in the number of EP infant admissions within the following regions: Asia, Eastern Europe, Southern Europe, Northern Europe, Western Europe, North America All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 5, 2020. . https://doi.org/10.1101/2020.10.02.20204578 doi: medRxiv preprint

2) The correlation between the level of the local lockdown restrictions and change in the number of EP infant admissions.

Exploratory outcomes were 1) the likelihood that restrictions inside or outside health institutions in the investigators country/region, have led to non-admittance of EP infants, 2) if any major changes in the organisation of perinatal care had occurred locally, which may have changed the number of admissions of EP infants and 3) the impact of the COVID-19 lockdown on the everyday life of a pregnant woman.

The total number of EP infant admissions, during the three months with the most rigorous lockdown restrictions in 2020, during the corresponding three months in 2019, within each region and within each level of lockdown restriction, were reported as numbers (n). The primary outcome, as well as the secondary outcome regarding the change in the number of EP infant admissions within each geographical region, were analysed using Chi-square tests for 1x2 tables. To analyse the correlation between the local level of lockdown restrictions and the change in number of EP infant admissions, we used simple linear regression. The exploratory outcomes did not undergo statistical analysis but were reported and discussed. For the primary outcome, an alfa level of 5% was chosen as a threshold for significance. To correct for multiple testing in the secondary outcomes, we chose an alfa level of 1%. Statistics were conducted in IBM SPSS Statistics 25 (IBM, Armonk, NY, US).

In a previous funding application for the SafeBoosC-III trial, we estimated that the 93 NICUs taking part in the application, had a total of 3000 EP infant admissions per year. Therefore, we expected Predefined regions based on the active SafeBoosC-III NICUs can be found in table 1 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 5, 2020. . https://doi.org/10.1101/2020.10.02.20204578 doi: medRxiv preprint perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted October 5, 2020. . https://doi.org/10.1101/2020.10.02.20204578 doi: medRxiv preprint perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted October 5, 2020. . https://doi.org/10.1101/2020.10.02.20204578 doi: medRxiv preprint radical or very radical (table 4) . Two out of 46 (4%) answered they thought the change had been little or very little. Investigators were furthermore asked to classify the likelihood that restrictions outside or inside health institutions in their country/region, could have led to non-admittance of EP infants. Thirty-four out of 46 (74%) answered that they thought it was unlikely or very unlikely (table 4) . Three out of 46 (7%) answered that they thought it was likely or very likely. To our knowledge, this study is the largest so far, evaluating the effect of the first phase of the COVID-19 pandemic on EP infant admissions. We exceeded the indicative sample size, which All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted October 5, 2020. . https://doi.org/10.1101/2020.10.02.20204578 doi: medRxiv preprint decreases the risk of type II errors, and to some extent compensates for the correction for multiple testing in the secondary outcomes (10). Furthermore, the protocol for this study was registered at clinicaltrials.gov before analysis of any data, thereby reducing the risk of selective outcome reporting bias (11).

As COVID-19 is an emergency, we decided to move quickly and therefore, the principal investigators only had three weeks (Aug 28 th -Sep 13 th , 2020) to report the data. It is plausible that the participation would have been better if we had prolonged the data collection time. Thirty-three NICUs of the SafeBoosC-III consortium did not participate in this study, for reasons which are uncertain. This imposes a potential bias. Furthermore, the data was self-reported, not verified by a third party, and collected in an unblinded fashion. We compared only with the corresponding time period in 2019. Numbers may have differed in the preceding years. It is also relevant to point out, that the three months where the lockdown restrictions were most rigorous, might not necessarily be the peak months in terms of COVID-19 cases. Thus, the results from this study do not reflect the number of admissions during the months with most COVID-19 cases. Simple and subjective judgements were used of the level of lockdown restriction, whether the lockdown had an impact on the life of pregnant women and whether lockdown restrictions could possibly lead to nonadmittance of EP infants. This may pose as a limitation in regards to response bias. It is plausible, however, that most of these biases would have induced a false association between the change in numbers and the possible explaining factors. Many of the principal investigators participating in this study, are representing NICUs from the same countries (e.g. five NICUs from Belgium). It is plausible that some EP infants are transferred between hospitals within the same country, which potentially could lead to a false high number of total admissions, since the same EP infant would count as an admission in more than one hospital. Such an issue would cause a false high number of admissions and thereby, a false high power. For EP infants re-admissions are likely, due to e.g. respiratory, gastro-intestinal or sensory problems. If re-admissions are included in the counted infants, this could also cause a false high power, however if it is done consistently for both 2019 and 2020 numbers, it will unlikely bias results. The analysis of number of admissions within each geographical region revealed no statistically significant differences between the three months where the lockdown restrictions were most rigorous in 2020 compared to the corresponding months of 2019. The p-values were adjusted to correct for multiple testing in the secondary outcome analyses.

Furthermore, the small number of admissions which each region increases the risk of type II errors (10). Thus, studies with a larger number of admissions within each geographical region are needed. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 5, 2020. . https://doi.org/10.1101/2020.10.02.20204578 doi: medRxiv preprint

The results from this study are contradictory to previously published literature (2) We have studied the immediate effects of lockdown. Delayed effects are also possible. The existence of neonatal networks and national registries will allow much stronger epidemiological studies to be done in the future, including examining the effects on the children themselves.

This larger ad hoc study did not confirm previous studies' report of a major reduction in the number of extremely preterm births during the first phase of the COVID-19 pandemic.

All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 5, 2020. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 5, 2020. . https://doi.org/10.1101/2020.10.02.20204578 doi: medRxiv preprint

This study was conducted utilising the SafeBoosC-III consortium and we sincerely thank the principal investigators for their cooperation and rapid data collection.

The sponsor/coordinating investigator, Professor of Paediatrics Gorm Greisen, is the initiator of the SafeBoosC-III project. He has no financial interest in the results of the trial. The Elsass Foundation, Aage and Johanne Louis-Hansen Foundation, and Svend Andersen Foundation supported the SafeBoosC-III trial through unconditional and unrestricted grants of DKK 2,700,000, DKK 1,000,000 and DKK 1,000,000, respectively. These funding sources had no role in the design of this study and will not have any role during its execution, analysis, interpretation of the data or decision to submit results.

The datasets used and/or analysed during the current study are available from the corresponding author on request and will be published on www.safeboosc.eu

The authors declare that they have no competing interests.

MIR, MLH and GG contributed to the conception and design of the study, drafted the protocol, collected data, drafted the manuscript, and will give final approval of the version to be perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted October 5, 2020. perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted October 5, 2020. . https://doi.org/10.1101/2020.10.02.20204578 doi: medRxiv preprint 9) On a scale from 1-5, one being no change in society and five being very strong change, would you describe the most rigorous restrictions in your country during the three peak months of the COVID-19 pandemic. Please base your answer on the following figure below:

Tick the box with an x, which you find most correct: 1 2 3 4 5 All rights reserved. No reuse allowed without permission.

perpetuity.

preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in

The copyright holder for this this version posted October 5, 2020. . https://doi.org/10.1101/2020.10.02.20204578 doi: medRxiv preprint

Oxford covid-19 government response tracker

Danish premature birth rates during the COVID-19 lockdown

Unprecedented reduction in births of very low birthweight (VLBW) and extremely low birthweight (ELBW) infants during the COVID-19 lockdown in Ireland: a 'natural experiment' allowing analysis of data from the prior two decades

Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational study. The Lancet Global Health

Hypothesis testing, type I and type II errors. Industrial psychiatry journal

During Coronavirus Lockdowns, Some Doctors Wondered: Where Are the Preemies? The New York Times

COVID-19 and readjusting clinical trials. The Lancet

Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial

Alert system overview | Unite against COVID-19